Posttransplant survival is not diminished in heart transplant recipients bridged with implantable left ventricular assist devices.

[1]  R. Patten,et al.  The effect of ventricular assist devices on post-transplant mortality an analysis of the United network for organ sharing thoracic registry. , 2009, Journal of the American College of Cardiology.

[2]  Andrew Boyle,et al.  Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. , 2008, The Annals of thoracic surgery.

[3]  J. Cleveland,et al.  Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival. , 2008, The Journal of thoracic and cardiovascular surgery.

[4]  Jason D. Christie,et al.  Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report--2008. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[5]  P. Noirhomme,et al.  Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[6]  O H Frazier,et al.  Use of a continuous-flow device in patients awaiting heart transplantation. , 2007, The New England journal of medicine.

[7]  M. Slaughter,et al.  Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  O. Frazier,et al.  Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease? , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  N. Smedira,et al.  Early and Midterm Risk of Coronary Allograft Vasculopathy in Patients Bridged to Orthotopic Heart Transplantation with Ventricular Assist Devices , 2005, Transplantation.

[10]  R. Dowling,et al.  HeartMate VE LVAS design enhancements and its impact on device reliability. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[11]  M. Oz,et al.  Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. , 2001, The Journal of thoracic and cardiovascular surgery.

[12]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[13]  O H Frazier,et al.  Surgery for Acquired Cardiovascular Disease Initial experience with the AbioCor Implantable Replacement Heart System , 2004 .